dienogest has been researched along with Hemorrhage, Uterine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasagawa, T; Takagi, H; Takakura, M | 1 |
| Hayashi, K; Kanda, S; Osuga, Y | 1 |
| Ali, MK; Hassanin, AI; Yousef, AM; Youssef, AA | 1 |
| Kurabayashi, T; Tamura, M; Tsuneki, I; Yanase, T | 1 |
| Harada, T; Taniguchi, F | 1 |
| Kitawaki, J; Kusuki, I; Suganuma, I; Yamanaka, K | 1 |
| Helmerhorst, FM; Lopez, LM; Raps, M; Van Vliet, HA | 1 |
| Morikawa, A; Nagata, C; Ochiai, K; Okamoto, A; Okamoto, S; Sugimoto, K; Tanaka, T; Yanagida, S | 1 |
| Chaya, J; Hayashi, K; Kato, N; Nishino, K; Yamamuro, O | 1 |
| von Schoultz, B | 1 |
| Gräser, T; Janaud, A; Römer, T; Wiedey, KD | 1 |
| Gräser, T; Koytchev, R; Müller, A; Oettel, M | 1 |
3 review(s) available for dienogest and Hemorrhage, Uterine
| Article | Year |
|---|---|
Dienogest: a new therapeutic agent for the treatment of endometriosis.
Topics: Animals; Dysmenorrhea; Endometriosis; Female; Hormone Antagonists; Humans; Male; Nandrolone; Ovary; Rabbits; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Hemorrhage | 2010 |
Quadriphasic versus monophasic oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medication Adherence; Menstruation; Nandrolone; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2011 |
Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
Topics: Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Nandrolone; Uterine Hemorrhage | 2003 |
5 trial(s) available for dienogest and Hemorrhage, Uterine
| Article | Year |
|---|---|
Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea.
Topics: Adult; Drug Administration Schedule; Dysmenorrhea; Female; Hormone Antagonists; Humans; Menstruation Disturbances; Nandrolone; Severity of Illness Index; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2020 |
Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial.
Topics: Adenomyosis; Adult; Contraceptives, Oral, Combined; Egypt; Female; Humans; Nandrolone; Pain Measurement; Uterine Hemorrhage | 2021 |
Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2011 |
Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
Topics: Aged; Bone Resorption; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endometrium; Estradiol; Europe; Female; Follicle Stimulating Hormone; Hormone Replacement Therapy; Hot Flashes; Humans; Lipoproteins; Middle Aged; Nandrolone; Patient Satisfaction; Postmenopause; Triglycerides; Ultrasonography; Uterine Hemorrhage | 2001 |
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Norethindrone; Postmenopause; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Uterine Hemorrhage | 2000 |
4 other study(ies) available for dienogest and Hemorrhage, Uterine
| Article | Year |
|---|---|
Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest.
Topics: Adenomyosis; Adult; Endometriosis; Female; Humans; Leiomyoma; Quality of Life; Retrospective Studies; Risk Factors; Uterine Hemorrhage | 2023 |
Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
Topics: Adult; Drug Administration Schedule; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest.
Topics: Adult; Endometriosis; Female; Hemoglobins; Humans; Middle Aged; Nandrolone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Uterine Hemorrhage | 2012 |
Effective salvage of acute massive uterine bleeding using intrauterine balloon tamponade in a uterine adenomyosis patient on dienogest.
Topics: Adenomyosis; Adult; Antineoplastic Agents, Hormonal; Female; Humans; Nandrolone; Uterine Balloon Tamponade; Uterine Hemorrhage | 2013 |